date:Jan 21, 2019
Danish-headquartered bioscience company Chr. Hansen has reported solid organic revenue growth of 10 percent in the first three months of the financial year 2018/19. It corresponds to 6 percent reported growth due to adverse currency impacts.
Health Nutrition (17 percent), Food Cultures Enzymes (10 percent) and Natural Colors (6 percent), all reported growth. EBIT before special items increased by 9 percent to 71 million, corresponding to an EBIT margin before special items of 26.3 percent, wh